Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1186 | Obesity | ICEECE2012

Insulin resistance and acne: a new risk factor for men?

Del Prete M. , Faggiano A. , Mauriello M. , Di Somma C. , Monfrecola G. , Fabbrocini G. , Colao A.

Introduction: Acne is a common skin disease that occasionally can be influenced by endocrine abnormalities. In females, a clear relationship has been highlight between acne onset and peripheral insulin resistance and hyperinsulinemia, whereas few data are available in male. The aim of this study was to investigate the relationship between acne and insulin resistance as well as other metabolic impairment in male subjects with acne.Methods/design: Twenty-t...

ea0029p132 | Bone & Osteoporosis | ICEECE2012

Osteoporosis and vitamin D deficiency in patients with lipid storage disease

Del Prete M. , Negri A. , Sarnataro M. , Pivonello C. , Ramundo V. , Marotta V. , Russo R. , Carratu A. , Cianciaruso B. , Colao A. , Pisani A. , Faggiano A.

Introduction: Bone metabolism is impaired in several lipid storage diseases. At now no data are available in Fabry disease (FD), a genetic lipid storage disease characterized by systemic accumulation of glicolipids. The aim of this study was to evaluate bone metabolism and calcium/vitamin-D pathway in patients with FD.Methods/design: Study population included 15 FD patients (8 M and 7 F, age 28–59 years) and 15 sex-, age- and BMI-matched normal subj...

ea0029p774 | Endocrine tumours and neoplasia | ICEECE2012

Diagnostic and Prognostic Role of 68GA-Dotatate in Patients with Neuroendocrine Tumors

Marciello F. , Faggiano A. , Aloj L. , Caraco C. , Ramundo V. , Marotta V. , Del Prete M. , Carratu A. , Colao A. , La Storia S.

Octreoscan is currently the gold standard for diagnosis of somatostatin receptor positive NET but it is limited by a lower spatial resolution and physiological uptake noises. DOTATATE is a somatostatin analogue, radiolabelled with 68Ga and adapted for PET imaging.Aim of this study was to evaluate the diagnostic performance of 68Ga-DOTATATE PET compared to Octreoscan in NET.Fifty-one patients with NET (40 sporadic, 17 MEN1) of diffe...

ea0029p779 | Endocrine tumours and neoplasia | ICEECE2012

Sorafenib stops disease progression in the majority of patients with advanced differentiated thyroid cancer refractory to radioactive iodine.

Marotta V. , Ramundo V. , Del Prete M. , Marciello F. , Palmieri G. , Camera L. , Vitale M. , Colao A. , Faggiano A.

Differentiated thyroid cancers (DTC) have an excellent prognosis with a 10 year disease-related survival of 85%. However, about 5% of DTC patients develop an aggressive disease with distant metastasis and loss of radioactive iodine (RAI) avidity. An effective treatment is not available for these patients and survival rates are less than 15%. The MAP-kinase pathway is strikingly involved in the pathogenesis of DTC. This is why compounds striking the MAP-Kinase pathway may be us...

ea0029p807 | Endocrine tumours and neoplasia | ICEECE2012

Long-acting somatostatin analogues are highly effective in men1 patients with early stage duodeno-pancreatic neuroendocrine tumors

Faggiano A. , Ramundo V. , Del Prete M. , Marotta V. , Marciello F. , Camera L. , Napolitano V. , De L. , Lombardi G. , Colao A.

Somatostatin analogues (SSA) represent a recognized therapeutic option in patients affected with functioning neuroendocrine tumors (NET). In non-functioning NET, SSA are reported to induce tumor stabilization in most of cases and objective response in <5%. NET associated to Multiple Endocrine Neoplasia type 1 (MEN1) are inherited tumors, generally located in the duodeno-pancreatic trait, characterized by well differentiated histotype, high expression of somatostatin recept...